The AI engine Fit Assessment
BetaRo5 leverages machine learning to enhance drug discovery, identify patterns, and expand therapeutic options, including drug repurposing efforts for COVID-19.
Blurb
HQ Location
Founded
Employees
Total funding raised
Funding Status
Accessible AI for all drug discovery researchers.
At Ro5, we provide the benefits of AI and digital transformation through a software platform that empowers our clients to focus on what they’re best at - drug discovery.
Ro5 makes AI accessible to the industry by providing the expertise, infrastructure, software, models, and data necessary for digital transformation. Our software products are developed for real-world challenges, solving the unique problems faced by our clients that focus on R&D. Our solutions augment researcher’s workflows, enable data-driven decisions, and accelerate research.
Ro5 has 5 years of experience providing services and software for pharmaceutical companies and CROs in projects spanning the entire drug discovery and development pipeline. Ro5 has a growing portfolio of scientific publications with 3 papers and 13 awarded patents.
Contact us to learn more about how Ro5’s platforms and digital transformation could help achieve your and your organization’s research goals.